Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Jan 22, 2018 (9 years ago)

Oxycodone Hydrochloride Tablets

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Labeling; Label Error Not Elsewhere Classified; label missing controlled substance CII symbol

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

Oxycodone Hydrochloride Tablets, USP 15 mg, 100 count bottles, Rx only, Manufactured for Camber Pharmaceuticals, Inc., Piscataway, NJ, Manufactured by: Ascent Pharmaceuticals, Inc., Central Islip, NY --- NDC 31722-917-01

Affected NDC 31722-0917-01

Compare with the code on your package — it is the most precise check available.

Drug: Oxycodone

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Oxycodone Hydrochloride
NDC 31722-0917
15 mg/1 Tablet
Oral
Camber Pharmaceuticals Inc Rx · CII
Recalling firm
Ascent Pharmaceuticals, Inc.
NDC code
31722-917-01
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0248-2018 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Oxycodone recalls

See all
Class II · Moderate risk

Oxycodone Hydrochloride Tablets

Defective container: card seal defects (weak/non-existent seals), leading to the tablets falling out of their cavities.

Ongoing Packaging defect Amerisource Health Services LLC NDC 68084-354-01 D-0338-2026

Other recalls by Ascent Pharmaceuticals, Inc.

All 2018 recalls